Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Arno M. Wiersema"'
Publikováno v:
Pilot and Feasibility Studies, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background Arterial thrombo-embolic complications (TEC) are still common during and after non-cardiac arterial procedures (NCAP). While unfractionated heparin has been used during NCAP for more than 70 years to prevent TEC, there is no conse
Externí odkaz:
https://doaj.org/article/9cd2bcaba4034cd3b61d96958a83a441
Autor:
Andrew Holden, MBChB, EBIR, Andrew A. Hill, MD, Manar Khashram, MBChB, PhD, Jan M.M. Heyligers, MD, PhD, Arno M. Wiersema, MD, PhD, Paul D. Hayes, MD, Michel M.P.J. Reijnen, MD, PhD
Publikováno v:
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 9, Iss 3, Pp 101241- (2023)
Preprocedural image analysis and intraprocedural techniques to fully treat infrarenal abdominal aortic aneurysm sacs outside of the endograft with shape memory polymer (SMP) devices during endovascular aneurysm repair were developed. Prospective, mul
Externí odkaz:
https://doaj.org/article/3a97f4793d31428b90c1ab29e260e11e
Autor:
Arno M. Wiersema, Liliane C. Roosendaal, Mark J. W. Koelemaij, Jan G. P. Tijssen, Susan van Dieren, Jan D. Blankensteijn, E. Sebastian Debus, Saskia Middeldorp, Jan M. M. Heyligers, Ymke S. Fokma, Michel M. P. J. Reijnen, Vincent Jongkind
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-16 (2021)
Abstract Background Heparin is used worldwide for 70 years during all non-cardiac arterial procedures (NCAP) to reduce thrombo-embolic complications (TEC). But heparin also increases blood loss causing possible harm for the patient. Heparin has an un
Externí odkaz:
https://doaj.org/article/960975c75da441748afb415e14ef7f44
Autor:
Jorn P. Meekel, Menno E. Groeneveld, Natalija Bogunovic, Niels Keekstra, René J. P. Musters, Behrouz Zandieh-Doulabi, Gerard Pals, Dimitra Micha, Hans W. M. Niessen, Arno M. Wiersema, Jur K. Kievit, Arjan W. J. Hoksbergen, Willem Wisselink, Jan D. Blankensteijn, Kak K. Yeung
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
Abstract The pathophysiology of aortic aneurysms (AA) is far from being understood. One reason for this lack of understanding is basic research being constrained to fixated cells or isolated cell cultures, by which cell-to-cell and cell-to-matrix com
Externí odkaz:
https://doaj.org/article/9643e47c11644d7eb054de8537310ecc
Autor:
Arno M. Wiersema, Christopher Watts, Alexandra C. Durran, Michel M. P. J. Reijnen, Otto M. van Delden, Frans L. Moll, Jan Albert Vos
Publikováno v:
Scientifica, Vol 2016 (2016)
A large variety exists for many aspects of the use of heparin as periprocedural prophylactic antithrombotics (PPAT) during peripheral arterial interventions (PAI). This variation is present, not only within countries, but also between them. Due to a
Externí odkaz:
https://doaj.org/article/0c585eab758542d9b41da060049073b7
Autor:
Liliane C. Roosendaal, Arno M. Wiersema, Juri W. Smit, Orkun Doganer, Jan D. Blankensteijn, Vincent Jongkind
Publikováno v:
European Journal of Vascular and Endovascular Surgery, 64(5), 557-565. W.B. Saunders Ltd
Roosendaal, L C, Wiersema, A M, Smit, J W, Doganer, O, Blankensteijn, J D & Jongkind, V 2022, ' Editor's Choice – Sex Differences in Response to Administration of Heparin During Non-Cardiac Arterial Procedures ', European Journal of Vascular and Endovascular Surgery, vol. 64, no. 5, pp. 557-565 . https://doi.org/10.1016/j.ejvs.2022.08.005
Roosendaal, L C, Wiersema, A M, Smit, J W, Doganer, O, Blankensteijn, J D & Jongkind, V 2022, ' Editor's Choice – Sex Differences in Response to Administration of Heparin During Non-Cardiac Arterial Procedures ', European Journal of Vascular and Endovascular Surgery, vol. 64, no. 5, pp. 557-565 . https://doi.org/10.1016/j.ejvs.2022.08.005
Objective: Females are more prone to complications during non-cardiac arterial procedures (NCAPs) than males. The current study investigated the difference in the effect of peri-procedural prophylactic heparin in males and females, using the activate
Autor:
Orkun Doganer, Liliane C. Roosendaal, Arno M. Wiersema, Jan D. Blankensteijn, Kak Khee Yeung, Vincent Jongkind
Publikováno v:
Doganer, O, Roosendaal, L C, Wiersema, A M, Blankensteijn, J D, Yeung, K K & Jongkind, V 2022, ' Weight Based Heparin Dosage with Activated Clotting Time Monitoring Leads to Adequate and Safe Anticoagulation in Non-Cardiac Arterial Procedures ', Annals of Vascular Surgery, vol. 84, pp. 327-335 . https://doi.org/10.1016/j.avsg.2022.01.029
Annals of Vascular Surgery, 84, 327-335. Elsevier Inc.
Annals of Vascular Surgery, 84, 327-335. Elsevier Inc.
Background: Unfractionated heparin has an unpredictable effect in an individual patient. The activated clotting time (ACT) can be used to measure the effect of heparin in the individual patient and guide additional heparin dosages. Previous cohort st
Autor:
Liliane C. ROOSENDAAL, Willemijn van den ANCKER, Arno M. WIERSEMA, Jan D. BLANKENSTEIJN, Vincent JONGKIND
Publikováno v:
The Journal of Cardiovascular Surgery.
Publikováno v:
the ACTION-1 research collaborative 2023, ' Activated Clotting Time Guided Heparinisation During Open Abdominal Aortic Aneurysm Repair (ACTION-1)-Rationale and Design of a Randomised Trial ', European Journal of Vascular and Endovascular Surgery, vol. 65, no. 3, pp. 451-452 . https://doi.org/10.1016/j.ejvs.2023.01.006
European Journal of Vascular and Endovascular Surgery, 65(3), 451-452. W.B. Saunders Ltd
European Journal of Vascular and Endovascular Surgery, 65(3), 451-452. W.B. Saunders Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a53cd7584c04a0cd5f629d090c289f1
https://research.vumc.nl/en/publications/a0eff171-00b8-4a8d-afd6-bb709def0534
https://research.vumc.nl/en/publications/a0eff171-00b8-4a8d-afd6-bb709def0534
Autor:
Sabrina A.N. Doelare, Safae Oukrich, Kübra Ergin, Vincent Jongkind, Arno M. Wiersema, Rutger J. Lely, Harm P. Ebben, Kak K. Yeung, Arjan W.J. Hoksbergen
Publikováno v:
European Journal of Vascular and Endovascular Surgery, 65(3), 398-404. W.B. Saunders Ltd
Collaborators 2023, ' Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia : Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience ', European Journal of Vascular and Endovascular Surgery, vol. 65, no. 3, pp. 398-404 . https://doi.org/10.1016/j.ejvs.2022.11.010
Collaborators 2023, ' Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia : Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience ', European Journal of Vascular and Endovascular Surgery, vol. 65, no. 3, pp. 398-404 . https://doi.org/10.1016/j.ejvs.2022.11.010
Objective: Regular measurement of fibrinogen as dose guidance in catheter directed thrombolysis (CDT) for acute limb ischaemia (ALI) has recently been dropped from European guidelines based on inconsistent literature. This study aimed to determine wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::165158223916da6185c8c833c294435e
https://research.vumc.nl/en/publications/9c3c58e6-3edb-4778-b370-0b610569e5c9
https://research.vumc.nl/en/publications/9c3c58e6-3edb-4778-b370-0b610569e5c9